Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2007-12-04
2007-12-04
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S316000, C544S330000
Reexamination Certificate
active
10483430
ABSTRACT:
A 2-(N-methyl-N-methanesulfonylamino)pyrimidine compound of the formula (3): [R is a hydrocarbyl group], is prepared by the steps of: (I) reacting an isobutyrylacetate ester with 4-fluorobenzaldehyde and urea in the presence of a protonic compound and a metal salt; (II) oxidizing the reaction product of the step (I); (III) reacting the oxidation product of the step (II) with an organic sulfonyl halide or an organic sulfonyl anhydride; and (IV) reacting the reaction product of the step (III) with N-methyl-N-methanesulfonamide.
REFERENCES:
patent: 5681957 (1997-10-01), Wolters et al.
patent: 6278001 (2001-08-01), Solladie et al.
patent: 6784171 (2004-08-01), Taylor et al.
patent: 6844437 (2005-01-01), Taylor et al.
patent: 6870059 (2005-03-01), Kooistra et al.
patent: 0742212 (1996-11-01), None
patent: 1193259 (2002-04-01), None
patent: 5-178841 (1993-07-01), None
patent: 6-256318 (1994-09-01), None
patent: 90/03973 (1990-04-01), None
patent: 92/01675 (1992-06-01), None
patent: WO 93/08823 (1993-05-01), None
patent: 96/14846 (1996-05-01), None
patent: 97/21687 (1997-06-01), None
patent: WO 97/19917 (1997-06-01), None
patent: 99/07695 (1999-02-01), None
patent: 00/49014 (2000-08-01), None
patent: WO 00/49014 (2000-08-01), None
patent: 00/78730 (2000-12-01), None
patent: 01/04100 (2001-01-01), None
patent: 01/60804 (2001-08-01), None
patent: WO 01/72706 (2001-10-01), None
patent: 01/85702 (2001-11-01), None
patent: WO 01/85975 (2001-11-01), None
patent: WO 02/06266 (2002-01-01), None
patent: WO 03/059901 (2003-07-01), None
patent: 03/097614 (2003-11-01), None
patent: WO 03/106447 (2003-12-01), None
patent: WO 2004/014872 (2004-02-01), None
patent: WO 2004/054986 (2004-07-01), None
patent: WO 2004/103977 (2004-12-01), None
patent: WO 2004/108691 (2004-12-01), None
patent: WO 2005/023779 (2005-03-01), None
patent: WO 2005/028450 (2005-03-01), None
patent: WO 2005/042522 (2005-05-01), None
patent: WO 2005/092867 (2005-10-01), None
patent: WO 2006/067456 (2006-06-01), None
Watanabe et al., “Synthesis and Biological Activity of Methanesulfonamide Pyrimidine- andN-Methanesulfonyl Pyrrole-Substituted 3,5-Dihydroxy-6-heptenoates, a Novel Series of HMG-CoA Reductase Inhibitors”, Bioorganic & Medicinal Chemistry, 1997, vol. 5, No. 2, pp. 437-444.
Grohe et al., Synthese und Reaktionen von 2,4-Dichlorpyrimidin-5-carbon-säuereestern, Libigs Ann. Chem., 1973, pp. 1025-1035.
Kaneko et al. “Preparation of optically active 5,6-epoxyhexanoic acid esters as materials for physiologically active substances” Chemical Abstracts+Indexes, American Chemical Society, Columbus, US 118(11):832 (1993).
Menges et al. “Oxidation Degradation of γ-Butyrolactons into 1,3-Diols via a Criegee Rearrangement of Peroxosulfonates. An Enantioselective Synthesis of Compactin Lactone and its Diastereomer” Synlett 12:901-905 (1993).
Presentation given at the 20th International Congress of Heterocyclic Chemistry in Palermo, Aug. 1-5, 2005.
Presentation given at the Gordon Conference on Heterocyclic Compounds, Salve Regina University, Newport, Rhode Island, Jul. 4-9, 2004.
Sakaki et al. “Lipase-catalyzed asymmetric synthesis of 6-(3-chloro-2-hydroxypropyl)-1,3-dioxin-4-ones and their conversion to chiral 5,6-epoxyhexanoates” Tetrahedron: Asymmetry 2(5):343-346 (1991).
Shao et al. “Asymmetric hydrogenation of 3,5-Dioxoesters catalyzed by Ru-binap complex: A short step asymmetric synthesis of 6-substituted 5,6-dihydro-2-pyrones” Tetrahedron 49(10):1997-2010 (1993).
Andrew J. Blacker et al., U.S. Appl. No. 10/275,092, filed Nov. 1, 2002, WO 01/85975, Nov. 15, 2001.
Robert P. Hof, U.S. Appl. No. 10/501,250, filed Jul. 8, 2004, WO 03/059901, Jul. 24, 2003.
Hermanus C. Bakel Van et al., U.S. Appl. No. 10/518,164, filed Jul. 25, 2005, WO 03/106447, Dec. 24, 2003.
John Horbury et al., U.S. Appl. No. 10/524,235, filed Feb. 10, 2005, WO 2004/014872, Feb. 19, 2004.
Lee Newton et al., U.S. Appl. No. 10/537,723, filed Jun. 7, 2005, WO 2004/054986, Jul. 1, 2004.
Jeffrey N. Crabb et al., U.S. Appl. No. 10/558,390, filed Nov. 29, 2005, WO 2004/108691, Dec. 16, 2004.
Rebecca J. Booth et al., U.S. Appl. No. 10/571,254, filed Mar. 9, 2006, WO 2005/023779, Mar. 17, 2005.
Simon N. Black et al., U.S. Appl. No. 10/572,635, filed Mar. 17, 2006, WO 2005/028450, Mar. 31, 2005.
Tetsuo Okada et al., U.S. Appl. No. 10/576,774, filed Apr. 21, 2006, WO 2005/042522, May 12, 2005.
Jacob H. Kooistra et al., U.S. Appl. No. 11/053,090, filed Feb. 7, 2005, WO 02/06266, Jan. 24, 2002.
Andrew J. Blacker et al., U.S. Appl. No. 11/412,047, filed Apr. 27, 2006, WO 01/85975, Nov. 15, 2001.
Hannah et al. “Structural studies on bioactive compounds. Part 29: palladium catalysed arylations and alkynylations of sterically hindered immunomodulatory 2-amino-5-halo-4,6-(disubstituted)pyrimidines” Bioorg Med Chem. 8(4):739-750 (2000).
Hauser et al. “Synthesis of 5-phenyl-4,6-dimethyl-2-pyrimidol and derivatives from the cyclization of urea with 3-phenyl-2,4-pentanedione” Journal of Organic Chemistry 18(5): 588-593 (1953).
Watanabe et al.; Bioorganic & Medicinal Chemistry, vol. 5, No. 2, 1997, pp. 437-444.
Ma et al., “Lanthanide Triflate Catalyzed Biginelli Reaction. One-Pot Synthesis of Dihydropyrimidinones under Solvent-Free Conditions,” Jouranl ofOrganic Chemistry, 2000, 65(12), 3864-3868.
Chika Jun-ichi
Kawachi Yasuhiro
Matsushita Akio
Oda Mizuho
AstraZeneca UK Limited
Balasubramanian Venkataraman
LandOfFree
Preparation of aminopyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of aminopyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of aminopyrimidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3885107